Tracheobronchial Secretion Removal

U

University of Milano Bicocca

Status

Completed

Conditions

Respiration, Artificial
Respiratory Insufficiency

Treatments

Device: Control
Device: TBA care device

Study type

Interventional

Funder types

Other

Identifiers

NCT00932776
AR HSG 268

Details and patient eligibility

About

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age greater than 18 years
  • presence of an endotracheal tube to provide mechanical ventilation
  • expected duration of mechanical ventilation greater than 48 hours.

Exclusion criteria

  • age < 18 years, pregnancy
  • presence of active bronchial bleeding

Trial design

0 participants in 2 patient groups

TBA
Experimental group
Treatment:
Device: TBA care device
Control
Active Comparator group
Treatment:
Device: Control

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems